Related Concepts
Related Feeds
Alzheimer's Disease: Early Markers
Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.
Alzheimer's Disease: Neuroimaging
Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.
Brain Injury & Trauma
brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.
Related Papers
Case Reports in Neurological Medicine
Shauna H Yuan, Sonya G Wang
JAMA : the Journal of the American Medical Association
Scott L ZuckermanAaron M Yengo-Kahn
JAMA : the Journal of the American Medical Association
Niloofar Yari
Neurology. Clinical Practice
Raquel C GardnerGil D Rabinovici
Nature Reviews. Neurology
Douglas H SmithWilliam Stewart